Skip Navigation



Home » Drug Information » FDA Approved Drugs » 1999
Medical Areas: Endocrinology | Musculoskeletal | Obstetrics/Gynecology (Women’s Health) | Family Medicine

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Evista (raloxifene hydrochloride)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Eli Lilly
Approval Status: Approved September 1999
Treatment Area: For the treatment of osteoporosis in postmenopausal women.

General Information

Tablet of raloxifene hydrochloride for the treatment of osteoporosis in post-menopausal women.

Mechanism of Action

Tablet, 60 mg.